Rare diseases
Investigational molecules
Locations
Back to Belgium1 932 clinical trials in Edegem, Belgium across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Phase 1/2 study of AVZO-023 drug combination in patients with advanced cancer
BelgiumPhase 1b study of empasiprubart in adults with multifocal motor neuropathy to assess nerve morphology by ultrasound
BelgiumGedatolisib with drug combination versus standard therapy as first‑line treatment for patients with advanced HR‑positive HER2‑negative breast cancer
BelgiumA Phase 3 Study of ASP2138 Plus Drug Combination in Adults with HER2‑Negative, CLDN18.2‑Positive Advanced Gastric Cancer (First‑Line Treatment)
BelgiumA Phase 2 Study of VS-7375 Alone or with Drug Combination in Patients with Metastatic KRAS G12D‑Mutated Colorectal Cancer
BelgiumA phase 1/2 study evaluating safety, pharmacokinetics and efficacy of SOT109 in patients with advanced unresectable or metastatic colorectal cancer
BelgiumStudy of Elritercept (TAK‑226) with Ruxolitinib vs Placebo in Patients with Myelofibrosis and Anemia on Ruxolitinib Therapy
BelgiumEffect of mitapivat versus placebo on transfusion burden in patients with sickle cell disease
BelgiumStudy on the Safety and Immune Response of GBS-NN/NN2 and Tdap Vaccines in Preventing Group B Strep Infection in Healthy Women Aged 18-49
BelgiumStudy of Human Normal Immunoglobulin in Adults with Secondary Immune Deficiency after CAR T‑cell or T‑cell Redirecting Therapy for Hematologic Malignancies
BelgiumRandomized trial of standard vs high-dose enoxaparin and sodium chloride for preventing clots in critically ill ICU patients at high risk of thrombosis
BelgiumA Randomized, Double‑Blind, Placebo‑Controlled Study of Momelotinib Dihydrochloride Monohydrate in Patients with VEXAS Syndrome
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on viral infections and vaccine development, including studies for influenza, RSV, and COVID-19. Multiple trials are evaluating immune responses and vaccine efficacy in different age groups.
Special attention is given to vulnerable populations, including elderly adults and pregnant women.
Innovative studies addressing Primary Biliary Cholangitis and Hepatitis D treatments. Research includes evaluation of novel therapeutics and their impact on disease progression.
Trials focus on improving patient outcomes and developing targeted treatments.
Advanced research in breast cancer and lung cancer treatments, exploring new therapeutic combinations and targeted approaches for better patient outcomes.
Focus on personalized medicine approaches and innovative treatment combinations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
